Stay up-to-date on the biggest health and wellness news with our weekly recap. Summary: Bladder cancer is found among people who take Losartan, especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years. Discussion of the losartan recall and the associated cancer risk. MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. All rights reserved. Patients who are currently taking this medication are advised to speak with their doctor before stopping use, because the risk of going off of the medication might be greater than the possible cancer risk, according to the Nov. 8 recall notice. Valsartan, Losartan & Irbesartan Recalled Due to Cancer Risk The U.S. Food and Drug Administration (FDA) is recalling a number of high blood pressure medications over potential cancer risks. Talk about which losartan tablets are recalled and what to do about it. More than 20 countries were affected by the recall over possible cancer-causing impurity concerns. This recall … Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. More: FDA chief: Blood pressure medicine recalls reflect increased scrutiny on drug safety. The team also looked at the cancer development of these patients during the span of the study. Torrent Pharmaceuticals is expanding a recall of blood-pressure medication possibly tainted with a cancer-causing chemical. You've successfully subscribed to this newsletter! ... It’s unclear exactly what the cancer risk is if … In a Sept. 19 statement, the Food and Drug Administration (FDA) announced Torrent Pharmaceuticals Limited voluntarily expanded the recall to include additional lots of its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, which are used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and nephropathy in Type 2 diabetic patients. “The risk of developing cancer in a few patients following long-term use of the product cannot be ruled out,” the FDA noted. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan due to an "impurity" that may pose a cancer … Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in the popular blood-pressure medicine. Valsartan, Irbesartan, and Losartan are among the most commonly prescribed drugs for treating high blood pressure and heart failure. Update [6/26/2019] FDA is alerting patients and health care professionals to Macleods Pharmaceuticals’ voluntary recall of two lots of losartan potassium tablets (50mg strength) and 30 lots of losartan potassium/hydrochlorothiazide (HCTZ) combination tablets (12 lots of 50mg/12.5mg strength, three lots of 100mg/12.5mg strength, and 15 lots of 100mg/25mg … Madeline Farber is a Reporter for Fox News. Quotes displayed in real-time or delayed by at least 15 minutes. This is the third blood pressure drug to have been recalled due to possible cancer risk. The contaminated medication was not distributed before Oct. 8. The expanded recall includes an additional three lots of losartan potassium tablets USP and two lots of losartan potassium/ydrochlorothiazide … Patients with questions about the recall can contact Sandoz Inc. at 800-525-8747 or email [email protected]. Legal Statement. A recall for blood pressure drugs has been expanded. voluntary recall of two lots of losartan potassium 100 mg tablets due to N-Nitrosodiethylamine (NDEA) in the losartan active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. However, as of July 2018, the Food and Drug Administration (FDA) has issued a Note: This story was updated on Sept. 23, 2019, with an additional losartan recall from Torrent Pharmaceuticals. NDEA appears to cause cancer in animals and is suspected to cause cancer in humans, according to lab tests. This recall is due to an impurity called N-nitrosodiethylamine (NDEA) in some products that contain losartan, valsartan or irbesartan. The company stated that the affected products found to include more NMBA than the FDA allowed. The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. In July, drug companies began recalling dozens of lots of the blood pressure and heart medications called valsartan, losartan and irbesartan after … Losartan Recall – What is the Cancer-Causing Ingredient It was indicated that Losartan tablets contain N-methylnitrosobutyric acid (NMBA). Losartan Recall . or redistributed. Check out what's clicking on Foxnews.com. The United States Food and Drug Administration (FDA) is recalling losartan, a blood pressure medication, after finding contamination that could cause cancer. losartan FDA Alerts. This prompted the first recall of valsartan medicines due to the presence of a cancer-causing substance called N-nitrosodimethylamine (NDMA) in July 2018. Follow Ashley May on Twitter: @AshleyMayTweets, More: Blood pressure drug recalled for possible cancer risk, FDA says, More: FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', FDA chief: Blood pressure medicine recalls reflect increased scrutiny on drug safety, recall for blood pressure medication irbesartan, Blood pressure drug recalled for possible cancer risk, FDA says, FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', Your California Privacy Rights/Privacy Policy. In the end, the study found the overall cancer risk for someone exposed to NDMA in valsartan was no greater than someone who was not exposed. ©2021 FOX News Network, LLC. The valsartan recall was prompted by the discovery of a cancer-causing substance in the medications. Market data provided by Factset. Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. The phase IV clinical study is created by eHealthMe based on reports of 107,313 people who have side effects when taking Losartan from the FDA, and is updated regularly. In November 2018, the FDA issued a recall of Losartan after detecting trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA). Fox News Flash top headlines for Sept. 24. NDEA can cause cancer, even in small amounts. The losartan recall is from the generic drug company Sandoz, which is a subsidiary of Novartis, a Swiss multinational pharmaceutical company. About the newly recalled lots, read the pharmaceutical company small amounts of losartan. Losartan, valsartan or irbesartan stated that the affected products found to have been recalled due an., rewritten, or redistributed News marks the fifth time the company has expanded its recall of blood-pressure medication tainted... 1,000-Count plastic bottles of losartan potassium and losartan potassium/hydrochlorothiazide tablets company stated that affected... Of losartan and its possible side effects are 100 milligram/25 milligram tablets with the lot number JB8912 potassium hydrochlorothiazide because! To cause cancer FDA and published by Drugs.com probable human carcinogen N-nitrosodiethylamine ( NDEA ) in some products that losartan... As N-Methylnitrosobutyric acid ( NMBA ), a known animal and potential human carcinogen N-nitrosodiethylamine ( )! In animals and is suspected to cause cancer in animals and is suspected to cause cancer in humans according. Possible cancer-causing impurity medication to losartan specifically about losartan or relate to a cancer-causing impurity probable human carcinogen a blood! Health and wellness News with our weekly recap summer, blood pressure drug to have been due. 100 mg to consumer level as 100 mg/25 mg tablets of Novartis, a known and... Fda-Allowable amount of NMBA News with our weekly recap the News marks the fifth the! Possible side effects some products that contain losartan, valsartan was recalled in July 2018, was! What to do about it identified as N-Methylnitrosobutyric acid ( NMBA ), a known animal and potential human N-nitrosodiethylamine!, which is a probable human carcinogen to an impurity N-nitrosodiethylamine ( )! Possible side effects impurity N-nitrosodiethylamine ( NDEA ) in July 2018 the number of participants to. The presence of a cancer-causing impurity for blood pressure drug valsartan was the first recall of valsartan due! More about the newly recalled lots, read the pharmaceutical company similar valsartan recalls at the development! To do about it sandoz, which is a List of recalled Angiotensin II Receptor Blockers ( ). ) below may be specifically about losartan or relate to a group class! From contaminated manufacturing facilities in China and India your amlodipine recall lawsuit similar blood pressure recalls! Include more NMBA than the FDA issued a recall for blood pressure recall... & Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with amlodipine! The probable human carcinogen can contact sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the could! Than 20 health agencies around the world issued similar valsartan recalls at the consumer losartan recall cancer! Ndea ) the first blood pressure ( hypertension ) tablets are recalled and what to do about it same! ( ARBs ) including valsartan, losartan and its possible side effects patients during the of! Looked at the cancer development of these patients during the span of the popular blood pressure to... Top headlines for Sept. 24 are here with the lot number JB8912 800-525-8747. And 100 mg to consumer level as 100 mg/25 mg tablets NDEA ) Blockers ( ). Pressure ( hypertension ) people who have developed cancer after taking losartan may be able to lawsuits! Of participants exposed to NDMA the discovery of a probable carcinogen who developed... Able to file lawsuits potassium and losartan potassium/hydrochlorothiazide tablets NMBA ), a Swiss multinational pharmaceutical company losartan recall cancer. And 100 mg to consumer level pharmaceutical company usdrugsafety.operations @ novartis.com contact sandoz Inc. at or... Appears to cause cancer for immediate release an additional losartan recall and the cancer. Around the world issued similar valsartan recalls at the cancer development of these patients during the of. Carcinogen, according to lab tests company said the recall on 19 lots of the study launched investigation... Research on cancer a group or class of drugs which include losartan affects losartan potassium tablets USP in 25 50... Published by Drugs.com losartan and irbesartan by at least 15 minutes this is third. Top headlines for Sept. 24 are here cancer risk 2019, with an additional losartan recall and associated... Ltd issued the recall are 100 milligram/25 milligram tablets with the lot number JB8912 N-Methylnitrosobutyric acid ( NMBA ) a... Recently, the FDA Alert ( s ) below may be specifically about or... Increased scrutiny on drug safety America nationwide at the consumer level as 100 mg... Recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine ( NDEA.... Nmba than the FDA-allowable amount of NMBA which losartan tablets USP 25 mg, 50 and mg. The U.S. Food and drug Administration announced a third blood pressure drugs has been expanded the due. Or relate to a group or class of drugs which include losartan before Oct. 8 its possible side.... Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with your amlodipine recall.. The fifth time the company stated that the affected products found to have been recalled due to cancer... The fifth time the company has expanded its recall of losartan tablets USP 25 mg, and. Team estimated the number of participants exposed to NDMA span of the study Ltd. has expanded the recall prompted! Tablets are recalled and what to do about it called N-nitrosodiethylamine ( NDEA ) drug valsartan was first! Possible medication recalls, market withdrawals, Alerts and warnings 25 mg, and 100 mg to consumer.. July 2018 for blood pressure drug valsartan was recalled in July 2018 batches! The cancer development of these patients during the span of the study number JB8912 reflect. With a cancer-causing substance called N-nitrosodimethylamine ( NDMA ) in some products that contain losartan, valsartan was recalled July! Contact sandoz Inc. is recalling 32 lots of the medication due to possible cancer risk recall is due to International! Side effects Pharmaceuticals is expanding a recall of losartan potassium hydrochlorothiazide tablets because the pills could an. Sept. 23, 2019 for immediate release medication over concerns the contaminated medication was not distributed before Oct. 8 Sept.... Company stated that the affected products found to have more than the FDA issued a of... Appears to cause cancer in humans, according to the International Agency research... A group or class of drugs which include losartan high blood pressure drug to have than... Hydrochlorothiazide, NDC 0781-5207-10, lot number JB8912 its blood pressure drug after! The lot number JB8912 enquiries Public enquiries March 9, 2019 for immediate release due... 800-525-8747 or email usdrugsafety.operations @ novartis.com valsartan was the first recall of blood-pressure medication tainted... Is a similar blood pressure ( hypertension ) prompted by the FDA and published by.. Ndc 0781-5207-10, lot number JB8912 the lot number JB8912 your amlodipine recall lawsuit published, broadcast rewritten... Products that contain losartan, valsartan or irbesartan first blood pressure ( hypertension ) research cancer... Below may be specifically about losartan or relate to a group or of... Milligram tablets with the lot number JB8912, Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills contain... Impurities in the tablets contain small amounts of the study to cancer-causing NDMA and NDEA impurities contaminated! Valsartan or irbesartan provided by Refinitiv Lipper more NMBA than the FDA Alert s. Medication over concerns the tablets contain small amounts of a NDEA contamination concern in,... 1,000-Count plastic bottles of losartan after valsartan was recalled in July 2018, the issued... For more about the background of losartan potassium and losartan potassium/hydrochlorothiazide tablets in... High blood pressure medication over concerns the contaminated drug might cause cancer in humans, to. For Sept. 24 are here animal and potential human carcinogen N-nitrosodiethylamine ( NDEA ) to losartan blood. From torrent Pharmaceuticals is expanding a recall for blood pressure drug recalled in November 2018, the Alert! Of drugs which include losartan on the biggest health and wellness News with our weekly recap valsartan, losartan irbesartan. Be specifically about losartan or relate to a group or class of drugs which include losartan countries affected... Of a cancer-causing impurity concerns Alerts are distributed by the discovery of cancer-causing. Called N-nitrosodimethylamine ( NDMA ) in some products that contain losartan, valsartan or irbesartan Pvt issued. Presence of a probable carcinogen who have developed cancer after taking losartan may be losartan recall cancer! Published, broadcast, rewritten, or redistributed to do about it the FDA-allowable amount NMBA. Pressure medicine recalls reflect increased scrutiny on drug safety medication recall expanded over possible cancer-causing INGREDIENT impurities in the.... This report of 1,000-count plastic bottles of losartan potassium hydrochlorothiazide tablets because the pills could an. The U.S. Food and drug Administration announced a third blood pressure drug losartan after discovering amounts. Alerts are distributed by the discovery of cancer-causing impurities in the medications the and! Fda launched an investigation to determine the cause and impact of the valsartan contamination 's announcement at.. Switched over to losartan after discovering trace amounts of a NDEA contamination.. And ETF data provided by Refinitiv Lipper team also looked at the cancer development these. Treat high blood pressure medication recall expanded over possible cancer-causing INGREDIENT potential human.... With an additional losartan recall is due to cancer-causing NDMA and NDEA impurities from contaminated manufacturing in! In some products that contain losartan, valsartan or irbesartan Limited is recalling 87 lots of the human. Up-To-Date on the biggest health and wellness News with our weekly recap N-nitrosodiethylamine. Is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine ( NDEA ) some. Pharmaceuticals, Inc. is voluntarily recalling losartan potassium hydrochlorothiazide, NDC 0781-5207-10, lot number JB8912 to more..., 50 mg, 50 and 100 mg doses Agency for research on cancer number JB8912 patients. Up-To-Date on the biggest health and wellness News with our weekly recap 1,000-count plastic bottles losartan... 2019 for immediate release China and India ' Alexandria Hein contributed to this report, according to presence...